Physician profile
Chase D Rose
NPI 1467940288
$2,557.39
in general payments reported to CMS, 2019-2025
10 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what 81% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.92 · 2022: $185 · 2024: $128 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,244 · Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,244.33 |
| Food and Beverage | $1,075.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,785.54 | 2024-2025 | |
| Medtronic, INC. | $574.27 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $51.04 | 2025 | Intracept |
| Abbott Laboratories | $35.57 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $26.07 | 2025 | |
| Abbvie INC. | $22.28 | 2022 | |
| Biotronik Nro, INC. | $19.96 | 2025 | Prospera |
| Redhill Biopharma INC. | $19.11 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.24 | 2022 | |
| Grt US Holding, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.